News
Relief Reports that its U.S. Collaboration Partner Announces Data Safety Monitoring Board (DSMB) Update on the U.S. National Institutes of Health (NIH) Study of aviptadil in Critical COVID-19
Relief Reports that its U.S. Collaboration Partner Announces Data Safety Monitoring Board (DSMB) Update on the U.S. National Institutes of Health (NIH) Study of aviptadil in Critical COVID-19
DGAP-News: BB BIOTECH AG: Disruptive technologies are changing an entire industry
DGAP-News: BB BIOTECH AG: Disruptive technologies are changing an entire industry
Evolva successfully placed shares from authorized capital, raising CHF 6.3 million
Evolva successfully placed shares from authorized capital, raising CHF 6.3 million
Evolva business update: On track to reach 2022 guidance
Evolva business update: On track to reach 2022 guidance
Kuros Biosciences announces commercial launch of MagnetOs Easypack Putty in the U.S.
Kuros Biosciences announces commercial launch of
MagnetOs Easypack Putty in the U.S.
Update on the timeline for Vifor Pharma tender offer
Regulatory News:
CSL Limited (ASX: CSL; USOTC:CSLLY) yesterday announced an update regarding the Vifor Pharma AG acquisition. CSL has previously advised that it expected to be in a position to
Update zum Zeitplan des öffentlichen Kaufangebots für Vifor Pharma
Regulatory News:
CSL Limited (ASX: CSL; USOTC:CSLLY) hat gestern ein Update bezüglich der Übernahme der Vifor Pharma AG veröffentlicht. CSL hat zuvor mitgeteilt, dass das Unternehmen die
Evolva signs distribution agreement for its Veri-teTM Resveratrol for dietary supplements in Brazil
Evolva signs distribution agreement for its Veri-teTM Resveratrol for dietary supplements in Brazil
Relief Therapeutics Files Amendment No. 2 to its Registration Statement on Form 20-F with the U.S. Securities and Exchange Commission
Relief Therapeutics Files Amendment No. 2 to its Registration Statement on Form 20-F with the U.S. Securities and Exchange Commission
Relief Therapeutics to Participate in Industry and Investor Conferences in May
Relief Therapeutics to Participate in Industry and Investor Conferences in May
Acer Therapeutics and Relief Therapeutics Announce Presentation of ACER-001 Data at the Genetic Metabolic Dieticians International Conference
Acer Therapeutics and Relief Therapeutics Announce Presentation of ACER-001 Data at the Genetic Metabolic Dieticians International Conference
Relief Therapeutics Announces Notice of Annual General Meeting of RELIEF THERAPEUTICS Holding SA
Relief Therapeutics Announces Notice of Annual General Meeting of RELIEF THERAPEUTICS Holding SA
Evolva shareholders approve all proposed resolutions at the Annual General Meeting 2022
Evolva shareholders approve all proposed resolutions at the Annual General Meeting 2022
Edison Investment Research Limited: Basilea Pharmaceutica (BSLN): Renewed focus on anti-infectives
Edison Investment Research Limited: Basilea Pharmaceutica (BSLN): Renewed focus on anti-infectives
Kapruvia® approved by European Commission for the treatment of moderate-to-severe pruritus in hemodialysis patients
Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220427005801/en/
Vifor Fresenius Medical Care Renal Pharma (VFMCRP)
Kuros Biosciences continues strong commercial roll-out of MagnetOs bone graft
Kuros Biosciences continues strong commercial roll-out of MagnetOs bone graft
Relief Therapeutics' Wholly Owned Subsidiary, APR Applied Pharma Research, Receives Notice of Allowance of Key U.S. Patent Application Covering PKU GOLIKE(R)
Relief Therapeutics' Wholly Owned Subsidiary, APR Applied Pharma Research, Receives Notice of Allowance of Key U.S. Patent Application Covering PKU GOLIKE(R)
94th Vifor Pharma Group Annual General Meeting
Regulatory News:
At today’s 94th Annual General Meeting of Vifor Pharma Ltd., shareholders approved all proposed resolutions put forward by the Board of Directors. The Annual General Meeting was
94. Generalversammlung der Vifor Pharma Gruppe
Regulatory News:
An der heutigen 94. ordentlichen Generalversammlung der Vifor Pharma AG haben die Aktionäre alle Anträge des Verwaltungsrats genehmigt. Die Generalversammlung fand erneut
Relief Therapeutics Appoints Drew Cronin-Fine as Executive Director, Head of U.S. Marketing
Relief Therapeutics Appoints Drew Cronin-Fine as Executive Director, Head of U.S. Marketing
DGAP-Adhoc: BB Biotech AG publishes its interim report
DGAP-Adhoc: BB Biotech AG publishes its interim report
Relief Reports that its U.S. Collaboration Partner has Filed a New Breakthrough Therapy Designation Request for Aviptadil
Relief Reports that its U.S. Collaboration Partner has Filed a New Breakthrough Therapy Designation Request for Aviptadil
DGAP-News: BB BIOTECH AG: Increased investment level balanced by established core holdings
DGAP-News: BB BIOTECH AG: Increased investment level balanced by established core holdings
Kuros Biosciences's MagnetOs Flex Matrix Cleared by FDA for Spinal Indications
Kuros Biosciences's MagnetOs Flex Matrix Cleared by FDA for Spinal Indications